Related references
Note: Only part of the references are listed.Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus
Vincent C. Marconi et al.
CLINICAL INFECTIOUS DISEASES (2022)
Ruxolitinib in adult patients with secondary hemophagocytic lymphohistiocytosis
Philip S. Boonstra et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis
Camille Keenan et al.
FRONTIERS IN IMMUNOLOGY (2021)
Ruxolitinib in Patients With Chronic Active Epstein-Barr Virus Infection: A Retrospective, Single-Center Study
Yue Song et al.
FRONTIERS IN PHARMACOLOGY (2021)
A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis
Qing Zhang et al.
HAEMATOLOGICA (2021)
Low dose ruxolitinib plus HLH-94 protocol: A potential choice for secondary HLH
Han Wang et al.
SEMINARS IN HEMATOLOGY (2020)
Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis
Jingshi Wang et al.
HAEMATOLOGICA (2020)
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy
Georgia Griffin et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2020)
Ruxolitinib for steroid-resistant acute GVHD
Antonio Maria Risitano et al.
BLOOD (2020)
Ruxolitinib as first-line therapy in secondary hemophagocytic lymphohistiocytosis and HIV infection
Sergio Galvez Acosta et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
Falciparum malaria-induced secondary hemophagocytic lymphohistiocytosis successfully treated with ruxolitinib
Andre Fuchs et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Ruxolitinib in Alleviating the Cytokine Storm of Hemophagocytic Lymphohistiocytosis
Li Jianguo et al.
PEDIATRICS (2020)
Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis
Romain Levy et al.
BLOOD ADVANCES (2020)
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial
Asra Ahmed et al.
LANCET HAEMATOLOGY (2019)
Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib
Scott R. Goldsmith et al.
BLOOD ADVANCES (2019)
Hemophagocytic Lymphohistiocytosis
Hanny Al-Samkari et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience
Inuk Zandvakili et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience
Jessica Slostad et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
Srdan Verstovsek et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
Christina Gavegnano et al.
PLOS PATHOGENS (2017)
Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7years
Alison M. Schram et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis
Rupali Das et al.
BLOOD (2016)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro
Christina Gavegnano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis
Theodore S. Johnson et al.
JOURNAL OF IMMUNOLOGY (2014)
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
Share Paper
